These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4975656)

  • 1. In vitro effect of rifampin on mycobacteria.
    Lorian V; Finland M
    Appl Microbiol; 1969 Feb; 17(2):202-7. PubMed ID: 4975656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of atypical mycobacteria to rifampin.
    Molavi A; Weinstein L
    Appl Microbiol; 1971 Jul; 22(1):23-5. PubMed ID: 5111305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycobacterial activity of rifampin under in vitro and simulated in vivo conditions.
    Stottmeier KD; Kubica GP; Woodley CL
    Appl Microbiol; 1969 Jun; 17(6):861-5. PubMed ID: 4978926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.
    Wallace RJ; Nash DR; Steele LC; Steingrube V
    J Clin Microbiol; 1986 Dec; 24(6):976-81. PubMed ID: 3097069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial resistance of Mycobacterium tuberculosis in Northern Nigeria.
    Fawcett IW; Watkins BJ
    Tubercle; 1976 Mar; 57(1):71-3. PubMed ID: 59991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro chemotherapeutic combinations against isoniazid-resistant Mycobacterium tuberculosis and Mycobacterium fortuitum.
    Goldstein E; Eagle MC; LaCasse ML
    Appl Microbiol; 1971 Sep; 22(3):329-33. PubMed ID: 4330314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The susceptibility of mycobacteria to rifamide and rifampicin.
    Clark J; Wallace A
    Tubercle; 1967 Jun; 48(2):144-8. PubMed ID: 4293697
    [No Abstract]   [Full Text] [Related]  

  • 9. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
    Dickinson JM; Aber VR; Mitchison DA
    Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs.
    Bergmann JS; Woods GL
    J Clin Microbiol; 1998 Oct; 36(10):2940-3. PubMed ID: 9738047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect on Mycobacterium tuberculosis of rifamycin SV alone and combined with major bacillostatic agents].
    Coletsos PJ
    Rev Tuberc Pneumol (Paris); 1967; 31(1):17-30. PubMed ID: 4962522
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of mycobacteria growth indicator tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
    Reisner BS; Gatson AM; Woods GL
    Diagn Microbiol Infect Dis; 1995 Aug; 22(4):325-9. PubMed ID: 8582137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the MB/BacT mycobacterium detection system for susceptibility testing of Mycobacterium tuberculosis.
    Díaz-Infantes MS; Ruiz-Serrano MJ; Martínez-Sánchez L; Ortega A; Bouza E
    J Clin Microbiol; 2000 May; 38(5):1988-9. PubMed ID: 10790136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigation into the relationship of M ulcerans to M. buruli and other mycobacteria.
    Schröder KH
    Am Rev Respir Dis; 1975 Apr; 111(4):559-62. PubMed ID: 47730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis.
    David HL
    Appl Microbiol; 1970 Nov; 20(5):810-4. PubMed ID: 4991927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest.
    Wanger A; Mills K
    J Clin Microbiol; 1996 Jul; 34(7):1672-6. PubMed ID: 8784567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
    Makarevich NM; Rudoĭ NM
    Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726
    [No Abstract]   [Full Text] [Related]  

  • 20. [Accelerated determination of the Mycobacterium tuberculosis drug resistance with a semiliquid culture medium].
    Manicheva OA; Vishnevskiĭ BI; Miakotina EN
    Klin Lab Diagn; 2003 Jul; (7):50-2. PubMed ID: 12934337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.